Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Engler

Showing results (11-20 of 132) with videos related to

Pageof 14
Sort By:
Osteopathic Hospital Leadership|August 8, 1987
The rising cost of advertisingF R Engler
Bioprocess Technology|January 1, 1990
Cell disruption by homogenizerC R Engler
Bioprocess Technology|January 1, 1994
Protein purification process engineering. Cell breakageC R Engler
Osteopathic Hospital Leadership|March 11, 1987
Protecting medical record confidentiality: the right to privacy versus the right to knowF R Engler
Osteopathic Hospital Leadership|February 9, 1985
Effective communications: a commercial messageF R Engler
Osteopathic Hospital Leadership|June 9, 1987
Air Force healthcare and the military airlift commandF R Engler
FEBS Letters|January 23, 1984
Alpha 2 high molecular mass cysteine proteinase inhibitor: HMr alpha 2-CPI. An inhibitor of human liver cathepsin H as probed by kinetic studyM Pagano, R Engler
Applied Microbiology|April 1, 1971
Effect of the purification of virus antigens on the production of specific complement-fixing antibodiesR Engler, P Keairnes
Cardiovascular Drugs and Therapy|October 1, 1991
Proclivity of activated neutrophils to cause postischemic cardiac dysfunction: participation in stunning?K Mullane, R Engler
FEBS Letters|February 22, 1982
Inhibition of human liver cathepsin L by alpha-thiol proteinase inhibitorM Pagano, R Engler
Pageof 14

Showing results (11-20 of 132) with videos related to

Sort By:
Pageof 14
Osteopathic Hospital Leadership|August 8, 1987
The rising cost of advertisingF R Engler
Bioprocess Technology|January 1, 1990
Cell disruption by homogenizerC R Engler
Bioprocess Technology|January 1, 1994
Protein purification process engineering. Cell breakageC R Engler
Osteopathic Hospital Leadership|March 11, 1987
Protecting medical record confidentiality: the right to privacy versus the right to knowF R Engler
Osteopathic Hospital Leadership|February 9, 1985
Effective communications: a commercial messageF R Engler
Osteopathic Hospital Leadership|June 9, 1987
Air Force healthcare and the military airlift commandF R Engler
FEBS Letters|January 23, 1984
Alpha 2 high molecular mass cysteine proteinase inhibitor: HMr alpha 2-CPI. An inhibitor of human liver cathepsin H as probed by kinetic studyM Pagano, R Engler
Applied Microbiology|April 1, 1971
Effect of the purification of virus antigens on the production of specific complement-fixing antibodiesR Engler, P Keairnes
Cardiovascular Drugs and Therapy|October 1, 1991
Proclivity of activated neutrophils to cause postischemic cardiac dysfunction: participation in stunning?K Mullane, R Engler
FEBS Letters|February 22, 1982
Inhibition of human liver cathepsin L by alpha-thiol proteinase inhibitorM Pagano, R Engler
Pageof 14